NVST
Envista Holdings Corp
NYSE: NVST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$25.90
-2.23% today
Updated 2026-04-29
Market cap
$4.22B
P/E ratio
92.50
P/S ratio
1.55x
EPS (TTM)
$0.28
Dividend yield
—
52W range
$16 – $30
Volume
2.4M
Envista Holdings Corp (NVST) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | $5.99B | $5.84B | $6.16B | $6.88B | $6.57B | $6.59B | $6.61B | $5.35B | $5.68B |
| Cash & equivalents | — | $0.00 | $0.00 | $211.20M | $888.90M | $1.07B | $606.90M | $940.00M | $1.07B | $1.21B |
| Current assets | — | $794.50M | $786.80M | $1.00B | $1.59B | $1.84B | $1.42B | $1.74B | $1.79B | $2.03B |
| Total liabilities | — | $998.20M | $1.02B | $2.62B | $3.15B | $2.52B | $2.38B | $2.43B | $2.42B | $2.57B |
| Current liabilities | — | $628.20M | $641.00M | $709.20M | $1.68B | $1.21B | $1.24B | $780.80M | $878.70M | $852.60M |
| Long-term debt | — | $0.00 | $0.00 | $1.32B | $907.70M | $883.40M | $870.70M | $1.40B | $1.28B | $1.45B |
| Shareholder equity | — | $4.99B | $4.82B | $3.54B | $3.72B | $4.06B | $4.21B | $4.17B | $2.93B | $3.11B |
| Retained earnings | — | $0.00 | $0.00 | $93.10M | $126.40M | $466.90M | $731.40M | $631.20M | $-487.40M | $-440.40M |
| Accounts receivable | — | $463.10M | $459.80M | $443.60M | $301.70M | $331.90M | $393.50M | $407.50M | $363.00M | $429.60M |
| Inventory | — | $275.70M | $278.70M | $277.90M | $216.00M | $263.80M | $300.80M | $258.80M | $241.00M | $288.10M |
| Goodwill | — | $3.37B | $3.33B | $3.31B | $3.21B | $3.13B | $3.50B | $3.29B | $2.26B | $2.36B |